Expert Review of Neurotherapeutics (ISSN 1473-7175) provides expert reviews on the use of drugs and medicines in clinical neurology and neuropsychiatry. Coverage includes disease management, new medicines and drugs in neurology, therapeutic indications, diagnostics, medical treatment guidelines and neurological diseases such as stroke, epilepsy, Alzheimer's and Parkinson's.
Comprehensive coverage in each review is complemented by the unique Expert Review format and includes the following sections:
Expert Opinion - a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results
Article Highlights – an executive summary of the author’s most critical points
《Expert Review Of Neurotherapeutics》是一本由TAYLOR & FRANCIS LTD出版商出版的专业医学期刊,该刊创刊于2001年,刊期Monthly,该刊已被国际权威数据库SCIE收录。在中科院最新升级版分区表中,该刊分区信息为大类学科:医学 3区,小类学科:临床神经病学 3区;药学 3区;在JCR(Journal Citation Reports)分区等级为Q2。该刊发文范围涵盖临床神经病学等领域,旨在及时、准确、全面地报道国内外临床神经病学工作者在该领域取得的最新研究成果、工作进展及学术动态、技术革新等,促进学术交流,鼓励学术创新。2021年影响因子为4.287,平均审稿速度偏慢,4-8周。
大类学科 | 分区 | 小类学科 | 分区 | Top期刊 | 综述期刊 |
医学 | 3区 | CLINICAL NEUROLOGY 临床神经病学 PHARMACOLOGY & PHARMACY 药学 | 3区 3区 | 否 | 是 |
JCR分区等级 | JCR所属学科 | 分区 | 影响因子 |
Q2 | CLINICAL NEUROLOGY | Q2 | 4.287 |
PHARMACOLOGY & PHARMACY | Q2 |
影响因子 | h-index | Gold OA文章占比 | 研究类文章占比 | OA开放访问 | 平均审稿速度 |
4.287 | 63 | 7.82% | 19.78% | 未开放 | 偏慢,4-8周 |